» Articles » PMID: 9501814

Risk Factors Linked to Postoperative Morbidity in Patients with Hepatocellular Carcinoma

Overview
Journal Br J Surg
Specialty General Surgery
Date 1998 Mar 21
PMID 9501814
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to clarify the risk factors for morbidity as well as to establish an optimum surgical strategy for hepatocellular carcinoma (HCC).

Methods: The risk factors linked to postoperative complications were analysed in 388 patients over a 10-year period, according to the kind of operative procedure.

Results: Stepwise regression analysis revealed that the most important factors related to postoperative morbidity were: age, creatinine level and the histological grade of fibrosis for the bisegmentectomy; the presence of diabetes mellitus, blood urea nitrogen level, the indocyanine green dye retention rate at 15 min and blood loss for the segmentectomy; the presence of diabetes mellitus and blood loss for subsegmentectomy; the presence of diabetes mellitus, the aspartate aminotransferase level, and the total operating time for resection less than subsegmentectomy.

Conclusion: The most important risk factors were not always related to liver function tests, but instead to other coexisting conditions such as diabetes mellitus and operation stress including operating time and blood loss. Therefore, any future treatment strategy of hepatic resection for HCC should make every effort both to evaluate coexisting conditions carefully and to reduce operative stress as far as possible.

Citing Articles

Combination of advanced lung cancer inflammation index and nonalcoholic fatty liver disease fibrosis score as a promising marker for surgical procedure selection for hepatocellular carcinoma.

Hosoda K, Shimizu A, Kubota K, Notake T, Kitagawa N, Yoshizawa T Ann Gastroenterol Surg. 2024; 8(6):1096-1106.

PMID: 39502724 PMC: 11533005. DOI: 10.1002/ags3.12815.


Stage-by-stage analysis of the effect of blood transfusion on survival after curative hepatectomy for hepatocellular carcinoma-a retrospective study.

She W, Tsang S, Dai W, Chan A, Lo C, Cheung T Langenbecks Arch Surg. 2024; 409(1):83.

PMID: 38436871 DOI: 10.1007/s00423-024-03278-z.


Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy.

Wu J, Luo J, Jiang Z, Huang S, Chen G, Ran H World J Gastroenterol. 2023; 29(20):3168-3184.

PMID: 37346152 PMC: 10280795. DOI: 10.3748/wjg.v29.i20.3168.


Clearance of the liver remnant predicts short-term outcome in patients undergoing resection of hepatocellular carcinoma.

Miki A, Sakuma Y, Ohzawa H, Saito A, Meguro Y, Watanabe J World J Gastroenterol. 2022; 28(38):5614-5625.

PMID: 36304091 PMC: 9594014. DOI: 10.3748/wjg.v28.i38.5614.


A Case-Matched Analysis of Laparoscopic Liver Resection for Hepatocellular Carcinoma Located in Posterosuperior Segments of the Liver According to Adaption of Developed Techniques.

Kwon Y, Lee B, Cho J, Han H, Yoon Y, Lee H Medicina (Kaunas). 2022; 58(4).

PMID: 35454381 PMC: 9032568. DOI: 10.3390/medicina58040543.